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Implications for practice and research  
• The findings support that maternal coffee consumption is associated with 
marginally increased gestational length, decreased birth weight, but not preterm 
delivery.  
• More research is required to confirm cause and effects. 
 
Context 
The WHO recommends a maternal caffeine intake of below 300mg/day1 and the 
American College of Obstetricians and Gynecologists recommends less than 
200mg/day.2 A maternal diet should include the essential nutrients to optimise foetal 
development and an avoidance of contaminants. Caffeine is contained in coffee, tea, 
cocoa, energy drinks and many soft drinks and crosses the placental barrier to enter the 
foetus which lacks the appropriate enzymes to deactivate it.3 Consequently, caffeine 
metabolites accumulate in the foetal brain4 and in so doing may incur foetal and neonatal 
outcomes. Sengpiel and colleagues examined the relationship between maternal 
caffeine intake from different sources and gestational length, the risk of spontaneous 
preterm delivery and birth weight. 
 
Methods 
This cohort study invited Norwegian women with uncomplicated pregnancies to detail 
their caffeine intake from various sources at 3 time points during pregnancy (17, 22 and 
30 weeks gestation) via postal questionnaires. The study excluded women with 
complications and those who did not adequately complete all the required information. 
Data from a total of 59 123 participants were entered for analysis.  
 
Findings 
The results of the study identified that coffee, black tea, soft drinks and chocolate 
accounted for 98% of daily caffeine intake, with coffee being the main source of caffeine. 
The findings support that coffee consumption is associated with a marginal increase in 
gestational length, decreased birth weight, but not preterm delivery. Caffeine intake at all 
time points was significantly associated with decreased birth weight. Caffeine from 
coffee and soft drinks intake at 17 weeks had the strongest impact. This may be 
rationalised by Lawson’s hypothesis, which maintains that the placenta is smaller in a 
young foetus.5,6  
 
Commentary  
Fundamentally, the present study identified that consuming 100mg/day of coffee is 
associated with a marginal increase in gestational length by 5 to 8 hours. In relation to 
such a small increase in length of pregnancy, no major advantage or disadvantage can 
be derived, unless there is an already compromised foetus. The findings unveil no 
reason for the statistical association, which in essence invites further research to isolate 
specific variables of cause and effect. It could be that other substances in coffee sources 
are potential influencers of the specified outcomes. Also, although the recruitment was 
high, issues of accuracy concerning self-report scales are relevant to the method of data 
collection employed by Sengpiel and colleagues. For example, honesty and image 
management, introspective ability, understanding of questions and the accuracy of 
estimated caffeine consumed over each day may have skewed results. Outside of these 
methodological reservations, interesting and informative data was generated. 
 
The more salient result is the reduction in birth weight, which for a healthy neonate 
presents minimal challenge. However, where pre-existing compromise exists, for 
example, a malfunctioning placenta accompanied by an already small for gestational 
age foetus or neonate, pre-existing pathology may be augmented; an aspect also worthy 
of further research. The topic studied is about women’s choices about whether to drink 
caffeinated coffee during pregnancy or otherwise. To help women make this informed 
choice, midwives must provide evidence-based information about potential 
consequences.  
 
In essence, this study hypothesises the potential relationships between maternal 
coffee/caffeine intake and specified outcomes, suggesting that randomised controlled 
trials are needed to isolate cause and effect.. There is a clear dearth of rigorous 
research on the topic of caffeine intake during pregnancy in its variety of forms. Other 
areas worthy of exploration include measuring the effects of maternal caffeine intake in 
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